To understand how the Mayo Clinic became a superior healthcare brand, I talked with Leonard Berry, PhD, to understand their ...

Patients with metastatic colorectal cancer (mCRC) harboring BRAF V600E mutations benefitted from first-line treatment with the targeted therapies encorafenib and cetuximab plus a mFOLFOX6 chemotherapy ...

AMB-066 is a potential first-in-class treatment for CRC MRD ~20,000 patients diagnosed annually in U.S.; no currently approved therapies ...

The new patient tower is the first phase of a projected $3 billion expansion by Cooper.

Modifying the physical characteristics of microscopic biomaterials to interact seamlessly with the body's tissues could unlock safer and more effective cancer treatments, according to Virginia Tech ...

Not only is alcohol a risk to your liver, but it can also significantly increase your risk for multiple types of cancer, a ...

MD Anderson Cancer Center named Artemio Mier associate vice president of revenue cycle, patient business services.

Rice University chemist and director of the university’s Synthesis X Center Han Xiao and cancer biologist Dihua Yu of The ...

As part of The Wistar Institute’s Melanoma Research Center, the Villanueva lab pursues new ways to overcome the challenge of melanoma drug resistance. In this paper, the group took aim at melanomas ...

Heme iron in red meat, along with nitrates and nitrites added to processed meats, can damage cells lining the bowel, according to the MD Anderson Cancer Center in Texas. Fiber, meanwhile ...

Michal Mego, winner of 2024, ESET Science Award public prize, founded top research lab when he returned to Slovakia.

“Year after year, we observe a continued decline in cancer-related mortality, and that is very important,” said Dr. Mariana Chavez-MacGregor, a professor at The University of Texas MD Anderson ...